News
June 21 (Reuters) - The U.S. Food and Drug Administration has approved Bristol Myers Squibb's (BMY.N), opens ... to buy Mirati," Morningstar analyst Damien Conover said. He estimates just over ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results